Section one: Contracting authority
one.1) Name and addresses
Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
St Nicholas Hospital, Jubilee Road
Newcastle Upon Tyne
NE3 3XT
Contact
Mr Leigh Tidyman
Telephone
+44 1912467214
Country
United Kingdom
NUTS code
UKC - North East (England)
Internet address(es)
Main address
Buyer's address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://procontract.due-north.com/Advert/Index?advertId=b5e15d62-b4e0-eb11-810d-005056b64545
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://procontract.due-north.com/Advert/Index?advertId=b5e15d62-b4e0-eb11-810d-005056b64545
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
CON/217/RX4 = Supply of COBALT Drug Trial Requirements
Reference number
DN555498
two.1.2) Main CPV code
- 33600000 - Pharmaceutical products
two.1.3) Type of contract
Supplies
two.1.4) Short description
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust are seeking expressions of interest from capable bidders for the following opportunity:
COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)
Introduction
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW) and The University of Melbourne (UoM), Australia have successfully bid for funding to run 2 National, multi-site, placebo controlled clinical trial assessing if adjunctive Memantine use in patients with Lewy Body Dementia (LBD) and Parkinson’s Disease Dementia (PDD) has any effect on Clinical Global Impression (CGI) after 6 or 12 months. One trial will be based in the UK and sponsored by CNTW NHS FT and the second trial will be sponsored and run in Australia by The University of Melbourne (UoM). Both trials will run at the same time, use the same protocol, trial management and Investigational Medicinal Product (IMP). The trial will require active treatment with Memantine 5mg and 10mg tablets for a period of 12 months and the manufacture of a matching placebo 5mg and 10mg tablets.
The trial will be run in the UK by the Dementia Research Team at Newcastle Biomedical Research Centre and sponsored by CNTW NHS FT.
Full details of the opportunity can be found in the tender documents. To access these documents please 'express an interest' via the tender portal link detailed on this page.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKC - North East (England)
two.2.4) Description of the procurement
See II.1.4. Short description and Tender documents for further detail.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
54
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
10 August 2021
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.7) Conditions for opening of tenders
Date
10 August 2021
Local time
12:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.4) Procedures for review
six.4.1) Review body
Cumbria, Northumberland, Tyne & Wear NHS Foundation Trust
Newcastle Upon Tyne
Country
United Kingdom